Tech Company Financing Transactions
NED Biosystems Funding Round
On 8/2/2018, NED Biosystems raised $2 million in Series B investment from private investors.
Transaction Overview
Company Name
Announced On
8/2/2018
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Series B
Investors
private investors (Benjamin Griswold IV)
Proceeds Purpose
The funds raised to date will allow the company to initiate a Phase 2 clinical trial by early 2019 of NED-170, an investigational, oral combination therapy dosed daily, for both rare and common cancers.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
245 1st St. Riverview II 18th Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
NED Biosystems is an early-stage life sciences company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Operating Officer
Peter D'Errico
Founder
Rebecca Lambert
Browse more venture capital transactions:
Prev: 8/1/2018: Edmit venture capital transaction
Next: 8/2/2018: Appdiff venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs